In the hepatitis study CCP2 specific responses were observed in half of the hepatitis samples[38], whereas only 22% of the sera from pulmonary tuberculosis patients was citrulline specific for CCP1 peptide compared to 94% of the sera from RA patients[39]. This evidence concerns the gene AGBL2 and rheumatoid arthritis.